Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FK995
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,093
Award facts
- Contract value 100% obligated
- $12,092.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,092.50 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Myrbetriq ER 50 mg tablets in a quantity of 90 units. This non-competitive, firm fixed-price delivery order is set to be completed by January 21, 2026, with performance occurring at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026, which enables the delivery of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, specializing in delivering brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military treatment facilities and veteran healthcare systems. The company's parent entity, Cencora, Inc., maintains the primary IDC relationship with DLA and has demonstrated consistent capability in fulfilling government contracts for essential pharmaceutical commodities on a full and open basis. This specific delivery order for Myrbetriq, a urological medication, represents routine pharmaceutical procurement supporting the Defense Health Agency's medical supply requirements through the established prime vendor relationship.
Quick answers
Who was awarded contract SPE2DR26FK995?
SPE2DR26FK995 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FK995 worth?
The government has obligated $12,093 on SPE2DR26FK995.
Is contract SPE2DR26FK995 an order under another contract?
Yes. SPE2DR26FK995 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK995 competed?
The extent of competition for SPE2DR26FK995 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award